Rebecca Taub - See Remarks, Madrigal Pharmaceuticals, Inc

As of February 23, 2021


Rebecca Taub Net Worth

  • Net worth is estimated to be at least $515.91M
  • Owns at least 655,540 units of Madrigal Pharmaceuticals, Inc stock

Rebecca Taub Compensation at Madrigal Pharmaceuticals, Inc in 2020

  • Earned a $490,833 salary
  • Received a total compensation of $3,882,343

Rebecca Taub Trading

  • Largest purchase of shares was 73,526 units , worth over $21.14M on June 12, 2018
  • In total has made about 8 transactions over 5 years
  • Usually trades in March, with the busiest year in 2018 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Rebecca Taub Mailing Address

  • Mailing address is 750 Battery Street, Suite 330 San Francisco CA 94111 CA

Madrigal Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Bonus
Other Compensation
Total
Paul A. Friedman, M.D. 2020 $603,500 $3,468,500 $463,446 - - $4,535,446
Paul A. Friedman, M.D. 2019 $584,000 $5,122,000 $387,192 - - $6,093,192
Paul A. Friedman, M.D. 2018 $416,666 $4,907,500 $304,500 - - $5,628,666
Rebecca Taub, M.D. 2020 $490,833 $3,052,280 $339,230 - - $3,882,343
Rebecca Taub, M.D. 2019 $463,948 $4,531,120 $274,775 - - $5,269,843
Rebecca Taub, M.D. 2018 $385,416 $3,729,700 $225,330 - - $4,340,446
Remy Sukhija 2020 $337,500 $2,724,000 $274,680 $100,000 $2,722 $3,438,902
Marc R. Schneebaum 2020 $435,000 $2,219,840 $267,233 - $18,399 $2,940,472
Marc R. Schneebaum 2019 $421,000 $2,868,320 $223,298 - $20,034 $3,532,652
Marc R. Schneebaum 2018 $380,250 $2,748,200 $222,314 - $15,336 $3,366,100
Brian J. Lynch 2020 $425,417 $3,749,840 $260,946 - $11,690 $4,447,893
Brian J. Lynch 2019 $358,602 $3,506,859 $192,602 - $10,574 $4,068,637
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1157601/000119312521144922/d107927ddef14a.htm

Madrigal Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 30,000 units sold on August 19, 2020 by Bay City Capital Llc, Bay City Capital Management Iv Llc, Bay City Capital Fund Iv Lp and Bay City Capital Fund Iv Co Invesment Fund Lp worth over $3.29M
  • In the last 3 years, insiders at Madrigal Pharmaceuticals, Inc sold an estimated value of $446.89M and bought an estimated value of $25.24M
  • The most active traders are Fred B Craves, Director,  David Milligan, M.D., Director,  and Paul Friedman, Chief Executive Officer
  • Insider trading is most common in June, with the busiest year in 2020

MADRIGAL PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1